Connecticut SB 641: AN ACT REQUIRING MANUFACTURERS OF BRAND-NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

Status: REF. TO JOINT COMM. ON General Law (as of 2021-01-28)

State: Connecticut · Session: 2021 · Bill: SB 641

Subjects: Drugs, Pharmaceutical manufacturing companies

Sponsors: Looney, Martin M.

View Connecticut SB 641 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.